Current knowledge on ApoC-III suggests a multifaceted influence in several pathophysiological processes including TRLs metabolism, atherosclerosis, inflammations, glucose metabolism, and cardiovascular and neurological diseases [1]. This evidence concerns the gene APOC3 and atherosclerosis.